...
首页> 外文期刊>Radiation oncology >Intraoperative radiation therapy with the photon radiosurgery system in locally advanced and recurrent rectal cancer: retrospective review of the Cleveland clinic experience
【24h】

Intraoperative radiation therapy with the photon radiosurgery system in locally advanced and recurrent rectal cancer: retrospective review of the Cleveland clinic experience

机译:局部晚期和复发性直肠癌术中用光子放射外科手术系统进行放射治疗:克利夫兰临床经验的回顾性回顾

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Patients with locally advanced or recurrent rectal cancer often require multimodality treatment. Intraoperative radiation therapy (IORT) is a focal approach which aims to improve local control. Methods We retrospectively reviewed 42 patients treated with IORT following definitive resection of a locally advanced or recurrent rectal cancer from 2000–2009. All patients were treated with the Intrabeam? Photon Radiosurgery System (PRS). A dose of 5?Gy was prescribed to a depth of 1?cm (surface dose range: 13.4-23.1, median: 14.4?Gy). Median survival times were calculated using Kaplan-Meier analysis. Results Of 42 patients, 32 had recurrent disease (76%) while 10 had locally advanced disease (24%). Eighteen patients (43%) had tumors fixed to the sidewall. Margins were positive in 19 patients (45%). Median follow-up after IORT was 22?months (range 0.2-101). Median survival time after IORT was 34?months. The 3-year overall survival rate was 49% (43% for recurrent and 65% for locally advanced patients). Local recurrence was evaluable in 34 patients, of whom 32% failed. The 1-year local recurrence rate was 16%. Distant metastasis was evaluable in 30 patients, of whom 60% failed. The 1-year distant metastasis rate was 32%. No intraoperative complications were attributed to IORT. Median duration of IORT was 35 minutes (range: 14–39). Median discharge time after surgery was 7?days (range: 2–59). Hydronephrosis after IORT occurred in 10 patients (24%), 7 of whom had documented concomitant disease recurrence. Conclusions The Intrabeam? PRS appears to be a safe technique for delivering IORT in rectal cancer patients. IORT with PRS marginally increased operative time, and did not appear to prolong hospitalization. Our rates of long-term toxicity, local recurrence, and survival rates compare favorably with published reports of IORT delivery with other methods.
机译:背景技术患有局部晚期或复发性直肠癌的患者通常需要多模式治疗。术中放射治疗(IORT)是旨在改善局部控制的重点方法。方法我们回顾性分析了2000年至2009年间明确切除了局部晚期或复发性直肠癌后接受IORT治疗的42例患者。所有患者均接受束内治疗吗?光子放射外科系统(PRS)。规定5?Gy的剂量至1?cm的深度(表面剂量范围:13.4-23.1,中位数:14.4?Gy)。中位生存时间使用Kaplan-Meier分析计算。结果42例患者中,复发性疾病32例(占76%),局部晚期疾病10例(占24%)。 18名患者(43%)肿瘤固定在侧壁上。 19名患者(45%)的切缘阳性。 IORT后的中位随访时间为22个月(0.2-101)。 IORT后的中位生存时间为34个月。 3年总生存率为49%(复发患者为43%,局部晚期患者为65%)。 34例患者可评估局部复发,其中32%失败。 1年局部复发率为16%。 30例患者可评估远处转移,其中60%失败。 1年远处转移率为32%。没有术中并发症归因于IORT。 IORT的中位时间为35分钟(范围:14–39)。手术后中位出院时间为7天(范围:2–59)。 IORT后发生肾积水的患者有10例(24%),其中7例已证明有疾病复发。结论束内? PRS似乎是在直肠癌患者中提供IORT的安全技术。带有PRS的IORT手术时间略有增加,并且似乎没有延长住院时间。我们的长期毒性,局部复发率和生存率与已发表的有关其他方法的IORT递送报告相比具有优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号